trending Market Intelligence /marketintelligence/en/news-insights/trending/tC2an3-4ALzLdBplH-wRew2 content esgSubNav
In This List

Nabriva completes rights offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Nabriva completes rights offering

Nabriva Therapeutics AG raised $21 million in a rights offering.

It offered 588,127 common shares, including 3,267,750 American depositary shares, where each ADS represents a 10th of a common share.

The Austria-based biopharmaceutical company plans to use these funds for general corporate purposes, including working capital and pre-commercial activities.

Cantor Fitzgerald & Co. is financial adviser to Nabriva and is the sole book-running manager of the underwritten offering.

The expected delivery date is Dec. 19.